Collegium Pharmaceutical Ownership | Who Owns Collegium Pharmaceutical?
Collegium Pharmaceutical Ownership Summary
Collegium Pharmaceutical is owned by 114.77% institutional investors, 2.16% insiders. Blackrock funding, inc. /de is the largest institutional shareholder, holding 17.22% of COLL shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 6.21% of its assets in Collegium Pharmaceutical shares.
COLL Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Collegium Pharmaceutical | 114.77% | 2.16% | -16.94% |
Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
Industry | Specialty & Generic Drug Manufacturers Stocks | 26.69% | 10.91% | 62.39% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Blackrock funding, inc. /de | 5.56M | 17.22% | $159.17M |
Eventide asset management | 2.64M | 8.18% | $75.60M |
Rubric capital management lp | 2.35M | 7.28% | $67.33M |
Vanguard group | 2.28M | 7.08% | $65.40M |
Pacer advisors | 2.14M | 6.64% | $61.38M |
Invesco | 1.78M | 5.50% | $50.88M |
Renaissance | 1.66M | 5.15% | $47.60M |
Principal financial group | 1.65M | 5.10% | $47.13M |
State street | 1.44M | 4.46% | $41.17M |
Fuller & thaler asset management | 1.35M | 4.19% | $38.73M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Quantedge capital pte | 267.75K | 2.80% | $7.67M |
Eventide asset management | 2.64M | 1.38% | $75.60M |
Third avenue management | 203.40K | 1.13% | $5.83M |
Emerald mutual fund advisers trust | 569.57K | 0.99% | $16.32M |
Emerald advisers | 811.68K | 0.90% | $23.25M |
Rubric capital management lp | 2.35M | 0.86% | $67.33M |
Velan capital investment management lp | 28.68K | 0.71% | $821.83K |
Virtus investment advisers | 24.45K | 0.55% | $700.38K |
Tejara capital | 28.78K | 0.54% | $824.58K |
Summerhaven investment management | 23.91K | 0.42% | $684.91K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Rubric capital management lp | 2.35M | 0.86% | 1.10M |
Invesco | 1.78M | 0.01% | 289.33K |
Janus henderson group | 291.39K | 0.00% | 221.90K |
Ubs group | 200.52K | 0.00% | 164.30K |
Qube research | 217.81K | 0.01% | 149.67K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Pacer advisors | 2.14M | 0.13% | -447.16K |
Goldman sachs group | 219.71K | 0.00% | -355.53K |
Federated hermes | 3.07K | 0.00% | -327.43K |
Arrowstreet capital, limited partnership | - | - | -276.73K |
Jpmorgan chase | 82.69K | 0.00% | -194.51K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Raymond james financial | 84.88K | 0.00% | 84.88K | $2.43M |
F/m investments | 73.16K | 0.08% | 73.16K | $2.10M |
Knott david m jr | 32.93K | 0.34% | 32.93K | $943.36K |
Velan capital investment management lp | 28.68K | 0.71% | 28.68K | $821.83K |
Walleye capital | 24.51K | 0.00% | 24.51K | $702.27K |
Sold Out
Holder | Change |
---|---|
Lindbrook capital | -2.00 |
Mendota financial group | -4.00 |
Capital performance advisors llp | -22.00 |
Hollencrest capital management | -25.00 |
True wealth design | -50.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2024 | 239 | -5.16% | 37,025,520 | -3.74% | 114 | 0.81% | 105 | -25.53% | 93 | 22.37% |
Sep 30, 2024 | 252 | 8.15% | 38,464,415 | -2.96% | 119 | 0.79% | 141 | 8.46% | 76 | - |
Jun 30, 2024 | 233 | 0.43% | 39,636,436 | -0.49% | 122 | 0.81% | 130 | - | 76 | -3.80% |
Mar 31, 2024 | 232 | 18.97% | 39,833,483 | 1.57% | 123 | 0.84% | 130 | 42.86% | 79 | 2.60% |
Dec 31, 2023 | 195 | 11.43% | 39,219,213 | 1.31% | 121 | 0.92% | 91 | - | 77 | 28.33% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
iShares Core S&P Small-Cap ETF | 1.99M | 6.21% | 1.38K |
Eventide Gilead N | 1.34M | 4.27% | - |
FullerThaler Behavioral Sm-Cp Eq R6 | 1.31M | 4.15% | - |
Eventide Healthcare & Life Sciences I | 1.29M | 4.08% | - |
FullerThaler Behavioral Small-Cap Equity | 1.31M | 4.06% | - |
Vanguard Total Stock Mkt Idx Inv | 979.17K | 3.11% | - |
Vanguard US Total Market Shares ETF | 993.93K | 3.09% | - |
iShares Russell 2000 ETF | 832.30K | 2.59% | -7.21K |
Principal SmallCap R5 | 570.20K | 1.81% | -7.60K |
Principal U.S. Small Cap Equity | 581.90K | 1.80% | -4.40K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Mar 20, 2025 | Tupper Colleen | EVP & Chief Financial Officer | Sell | $36.18K |
Mar 21, 2025 | Tupper Colleen | EVP & Chief Financial Officer | Sell | $192.07K |
Mar 21, 2025 | Dreyer Scott | EVP & Chief Commercial Officer | Sell | $566.98K |
Mar 20, 2025 | Dreyer Scott | EVP & Chief Commercial Officer | Sell | $57.81K |
Mar 11, 2025 | Dreyer Scott | EVP & Chief Commercial Officer | Sell | $461.67K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q1 | - | 14 |
2024 Q4 | - | - |
2024 Q3 | - | 4 |
2024 Q2 | - | 6 |
2024 Q1 | - | 4 |
COLL Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools